Skip to main content

Articles

Page 1 of 12

  1. Pantoea spp., a non-encapsulated, non-spore-forming Gram-negative rod bacterium that belongs to the Erwiniaceae family, can be found as a colonizer in humans, plants, and the environment, such as water and soil. ...

    Authors: Brian C. Monk, Prakhar Vijayvargiya, Mohamed Hassanein, Zackary A. Knott, Neville R. Dossabhoy and Yoshitsugu Obi
    Citation: Renal Replacement Therapy 2024 10:55
  2. Venous air trap chamber designs vary considerably to suit specific continuous renal replacement therapy circuits, with key variables including inflow design and filter presence. Nevertheless, intrachamber flow...

    Authors: Kota Shimizu, Toru Yamada, Kazuhiro Moriyama, China Kato, Naohide Kuriyama, Yoshitaka Hara, Takahiro Kawaji, Satoshi Komatsu, Yohei Morinishi, Osamu Nishida and Tomoyuki Nakamura
    Citation: Renal Replacement Therapy 2024 10:54
  3. Constipation is a common complication in hemodialysis patients and can impact their quality of life. Elobixibat selectively inhibits ileal bile acid transporter to suppress bile acid reabsorption, increase the...

    Authors: Takefumi Shono and Hiroyuki Hyakutake
    Citation: Renal Replacement Therapy 2024 10:53
  4. Peritoneal-dialysis-associated peritonitis is a serious complication of peritoneal dialysis; prevention and treatment are crucial to reduce patient morbidity and mortality. Staphylococcus sciuri is an organism th...

    Authors: Héctor Raúl Ibarra-Sifuentes, Gustavo Abraham Canales-Azcona, Jaqueline Isabel Gómez-Arredondo, Jesús Alfredo Rodríguez-Sifuentes, Vanessa Vianey Ríos-López and Abraham Castellanos-Maldonado
    Citation: Renal Replacement Therapy 2024 10:52
  5. Sepsis 3 definitions have shifted the focus from nonspecific inflammation to sepsis as an organ dysfunction caused by a dysregulated host response to infection. Neutrophils have become therapeutic targets beca...

    Authors: Tomoyuki Nakamura, Kazuhiro Moriyama, Toshikazu Sakai, Yu Kato and Osamu Nishida
    Citation: Renal Replacement Therapy 2024 10:51
  6. In Japan dialyzers are classified as type I, II, III, IV, or V on the basis of the β2-microglobulin clearance. In 2023, Type V dialyzers were defined as super high-flux membrane dialyzers. Herein, we investigate ...

    Authors: Masanori Abe, Kan Kikuchi, Eiichiro Kanda, Atsushi Wada, Shigeru Nakai and Norio Hanafusa
    Citation: Renal Replacement Therapy 2024 10:50
  7. Despite improvement in the management of systemic lupus erythematosus (SLE) during the past two decades, 10–22% of patients with lupus nephritis (LN) will progress to end-stage renal disease (ESRD). Kidney tra...

    Authors: Xin Li, Chun Xiang Cao and Jian Chen
    Citation: Renal Replacement Therapy 2024 10:49
  8. Peritoneal dialysis (PD)-associated peritonitis is a serious complication that can lead to PD discontinuation and mortality. Tsukamurella species are uncommon opportunistic pathogens that can cause peritonitis, o...

    Authors: Ryo Yamaguchi, Mana Kashiwagi, Kiyomi Ichijo, Yu Kobayashi, Tomomi Matsuoka, Shu Horikoshi, Hiroyuki Takashima and Masanori Abe
    Citation: Renal Replacement Therapy 2024 10:48
  9. There are few reports of kidney disease caused by cryofibrinogen (CF). There are still many unknowns regarding its diagnosis, treatment, and prognosis.

    Authors: Sou Kobayashi, Yukiko Yamano, Kousuke Osawa, Mari Kusube, Yuki Hata, Takahiro Tsuji, Harumi Saeki, Emi Ibuki, Dedong Kang, Takashi Takaki, Kazuho Honda, Shin-ichi Araki and Seiji Hashimoto
    Citation: Renal Replacement Therapy 2024 10:47
  10. Pain is a stressful experience for patients receiving haemodialysis through arteriovenous fistulas. This systematic review assessed the effectiveness of different pharmacological interventions for reducing pai...

    Authors: Abdul Rehman Arshad, Umair Ijaz and Babar Rafique
    Citation: Renal Replacement Therapy 2024 10:46
  11. No studies have compared mortality between acetate-containing bicarbonate dialysate (ABD) and acetate-free bicarbonate dialysate containing citrate (AFD) in hemodialysis (HD) or online hemodiafiltration (OHDF)...

    Authors: Kazuyoshi Okada, Manabu Tashiro, Hiroyuki Michiwaki, Yusaku Tanaka, Syo Yamashita, Tomoko Inoue, Hisato Shima and Jun Minakuchi
    Citation: Renal Replacement Therapy 2024 10:44
  12. Limited data are available regarding the prevalence of medication-related problems (MRPs) in kidney transplant recipients. This study aimed to determine the prevalence and types of medication-related problems.

    Authors: Danyah Katlan, Hani Hasan, Mohammed Aseeri, Abrar Alsubhi and Sherin Ismail
    Citation: Renal Replacement Therapy 2024 10:43
  13. Difelikefalin, a potent and highly selective agonist of kappa opioid receptors, is used to treat moderate-to-severe pruritus in hemodialysis patients.

    Authors: Ichiei Narita, Yoshiharu Tsubakihara, Naoko Takahashi, Toshiya Ebata, Takuma Uchiyama, Masaya Marumo, Shota Okamura and Fumitake Gejyo
    Citation: Renal Replacement Therapy 2024 10:42
  14. Although 70% of Japanese individuals wish to die at home, the in-hospital death rate in Japan is 71%. The in-hospital death rate is more than 80% in dialysis patients, most of whom are hemodialysis patients. F...

    Authors: Hideaki Oka, Yuko Sakurai, Taro Kamimura, Taichi Murakami, Takeshi Sato, Takanari Kitazono and Toshiaki Nakano
    Citation: Renal Replacement Therapy 2024 10:41
  15. Corynebacterium is a rare but important cause of peritoneal dialysis (PD)-associated infection. A previous study reported that continued antibiotic use at the exit site is associated with increased Corynebacteriu...

    Authors: Kazuya Sugita, Naoki Washida, Jyunji Takahashi, Masashi Tsunematsu, Kozi Hosoya, Jun Ito, Yutaka Suzuki and Kiyotaka Uchiyama
    Citation: Renal Replacement Therapy 2024 10:40
  16. IgA nephropathy (IgAN) is a common primary glomerulonephritis leading to end-stage renal disease. Living donor kidney transplantation (LDKT) is considered a favorable treatment option, but IgAN recurrence rate...

    Authors: Jacob Schmidt, Lutz Liefeldt, Emre Baysal, Stella Töpfer, Julia Dagnæs-Hansen, Markus Lerchbaumer, Thorsten Schlomm, Bernhard Ralla, Frank Friedersdorff and Robert Peters
    Citation: Renal Replacement Therapy 2024 10:39
  17. To prevent the progression of diabetic nephropathy, educational programs to improve self-management are important. However, the effectiveness of educational programs to prevent worsening of diabetic kidney dis...

    Authors: Takashi Kemmochi, Michiyo Oka, Ayako Inokuma, Natsumi Shirato and Ryotaro Totsuka
    Citation: Renal Replacement Therapy 2024 10:38
  18. In Japan, home hemodialysis (HHD) has several benefits, including a favorable prognosis, enhanced quality of life (QOL) of patients, and cost-effectiveness. However, the caregiver’s burden in assisting patient...

    Authors: Saori Kuroda, Hiroki Yabe, Arisa Nagata, Chiaki Imoto, Miwa Oida, Yoko Kadoshima, Miki Fudoji, Yoshiko Miyashita, Shigeru Nakai and Ikuto Masakane
    Citation: Renal Replacement Therapy 2024 10:37
  19. This study aimed to compare the outcomes of living donor kidney transplantation with blood- and non-blood-related donors across multiple facilities. Previous reports comparing these outcomes have been single-c...

    Authors: Tomohiko Matsuura, Moe Toyoshima, Mitsuru Saitoh, Hayato Nishida, Shingo Hatakeyama, Shinya Maita, Reiichi Murakami, Jun Sugimura, Takaya Abe, Hirofumi Tomita, Hisao Saitoh, Norihiko Tsuchiya, Chikara Ohyama, Tomonori Habuchi and Wataru Obara
    Citation: Renal Replacement Therapy 2024 10:36
  20. Acute kidney injury (AKI) is linked to disease severity and prognosis in patients with coronavirus disease 2019 (COVID-19), and mortality increases even with milder stages. This study primarily investigated th...

    Authors: Verda Tuna, Emre Senturk, Gunseli Orhun, Ozlem Polat, Ilkay Anakli, Gulcin Alay, Emre Celiksoy, Mehmet Kilic, Mercan Mutlu, Esen Figen and Perihan Ergin Ozcan
    Citation: Renal Replacement Therapy 2024 10:35
  21. Previous studies describing relationships among body compositions, intradialytic hypotension (IDH), and mortality yielded inconsistent results. We studied associations between body composition and IDH, and bet...

    Authors: Sonoo Mizuiri, Yoshiko Nishizawa, Toshiki Doi, Aiko Okubo, Kenichi Morii, Kazuomi Yamashita, Yukari Suga, Koji Usui, Kenichiro Shigemoto and Takao Masaki
    Citation: Renal Replacement Therapy 2024 10:34
  22. Locomotive syndrome (LS) is a condition of reduced mobility (locomotive organ impairment) that is associated with reduced quality of life (QOL) in patients undergoing hemodialysis (HD), and effective intervent...

    Authors: Kou Kitabayashi, Suguru Yamamoto, Yumi Katano and Ichiei Narita
    Citation: Renal Replacement Therapy 2024 10:33
  23. Japanese peritoneal dialysis (PD) guidelines do not suggest applying mupirocin/gentamicin ointment to the exit sites of PD patients to prevent exit-site infection (ESI). The guidelines do not mention topical a...

    Authors: Nao Asai, Yasuhiro Suzuki, Akimasa Asai, Hiroshi Kinashi, Keisuke Kamiya, Junichiro Hagita, Naoya Matsuoka, Suzuka Kawamura, Sosuke Fukui, Hangsoo Kim, Makoto Yamaguchi, Takayuki Katsuno, Masashi Mizuno, Takuji Ishimoto and Yasuhiko Ito
    Citation: Renal Replacement Therapy 2024 10:32
  24. The prevention of hypomagnesemia is critical for improving the life expectancy of patients undergoing hemodialysis (HD). The administration of magnesium oxide (MgO) increases serum Mg concentrations; however, ...

    Authors: Takuya Yoshida, Taku Furukubo, Satoshi Izumi, Shigeichi Shoji and Tomoyuki Yamakawa
    Citation: Renal Replacement Therapy 2024 10:30
  25. Sub-Saharan African countries, including Tanzania, have a high burden of chronic kidney diseases (CKDs) and limited capacity for the provision of services. Tanzania and other countries in the region have made ...

    Authors: Francis F. Furia, Jaqueline G. Shoo, Paschal J. Ruggajo, Jonathan W. Mngumi, Gudila Valentine, Mahmoud A. Muhiddin, Njiku Kim, Isaack Mlatie, Moses Mulungu, Namala Mkopi, Mabula Kasubi, Elizabeth S. Moshi, Lameck Mnyanyu, Ramadhani Hamis, Deus Buma, Mary C. Mtolera…
    Citation: Renal Replacement Therapy 2024 10:29
  26. A polysulfone dialysis membrane containing both polyvinylpyrrolidone (PVP) and the novel hydrophilic polymer (NV polymer) has been developed in an attempt to modify the blood contact surface of the membrane. I...

    Authors: Yoshitaka Kurihara, Kozue Kobayashi, Shigeharu Umehara, Hiroshi Tsukao, Kenichi Kokubo, Kiyotaka Sakai, Masaru Kubota and Hirosuke Kobayashi
    Citation: Renal Replacement Therapy 2024 10:28
  27. It has been reported that survival on mild hypoalbuminemia due to high albumin leakage did not worsen in patients on hemodialysis (HD) or online hemodiafiltration (OHDF) even though the level of serum albumin ...

    Authors: Kazuyoshi Okada, Manabu Tashiro, Hiroyuki Michiwaki, Tomoko Inoue, Hisato Shima and Jun Minakuchi
    Citation: Renal Replacement Therapy 2024 10:27
  28. Plasmapheresis is an important preoperative desensitization treatment for ABO-incompatible living kidney transplantation. However, in cases with plasma exchange therapy (PET), it is necessary to consider the r...

    Authors: Takafumi Yagisawa, Taichi Kanzawa, Yuya Fujiwara, Taro Banno, Ayaka Saito, Rikako Oki, Kohei Unagami, Toshihito Hirai, Kazuya Omoto, Norio Hanafusa, Hideki Ishida and Toshio Takagi
    Citation: Renal Replacement Therapy 2024 10:26
  29. Angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) exert a renoprotective effect on patients with chronic kidney disease (CKD). Despite their benefit, one of their side ef...

    Authors: Haruki Mae, Takuya Fujimaru, Koutarou Shimoyama, Nozomi Kadota, Kasumi Konishi, Yugo Itou, Masahiko Nagahama, Fumika Taki and Masaaki Nakayama
    Citation: Renal Replacement Therapy 2024 10:24
  30. Approximately 16.4% of patients on hemodialysis (HD) in Japan are treated with intermittent infusion hemodiafiltration (I-HDF). However, large-scale data on clinical outcomes with this modality are lacking. Th...

    Authors: Masanori Abe, Kan Kikuchi, Atsushi Wada, Shigeru Nakai and Norio Hanafusa
    Citation: Renal Replacement Therapy 2024 10:23
  31. Few reports have been published on preoperative and long-term postoperative rehabilitation after kidney transplantation. Poor physical function after kidney transplantation is associated with adverse events; h...

    Authors: Tomoya Yamaguchi, Hiroki Yabe, Takayuki Sugiyama, Shinsuke Isobe, Yuma Hirano, Hideo Yasuda, Hideaki Miyake and Katsuya Yamauchi
    Citation: Renal Replacement Therapy 2024 10:22
  32. The International Society for Peritoneal Dialysis guidelines suggest lateral or downward exit positions for peritoneal dialysis (PD) catheter. In cases with straight inter-cuff design (used in Thailand), downw...

    Authors: Worapot Treamtrakanpon, Phanupong Phutrakool and Krit Pongpirul
    Citation: Renal Replacement Therapy 2024 10:21
  33. Although roxadustat has been reported to cause central hypothyroidism, the details of the mechanisms and clinical characteristics of patients who are prone to developing hypothyroidism with roxadustat are unce...

    Authors: Chikako Yamashita, Yuri Hirai, Toshiya Nishigaito, Kensuke Mitsumoto, Aya Mizumoto, Manabu Kawakami and Takashi Uzu
    Citation: Renal Replacement Therapy 2024 10:20
  34. The measurement properties of the falls efficacy scale have not been evaluated in patients on hemodialysis. This study determined the inter- and intrarater reliability, standard error of measurement, minimal d...

    Authors: Luciana Angélica da Silva de Jesus, Bruno Valle Pinheiro, Ana Beatriz Laguardia Almeida, Lara Fagundes Fonseca da Cunha, Gabriela Moreira Resende, Marco Aurelio Moreira-Júnior, Mauricio Becho Campos-Junior, Pelagia Koufaki, Leda Marília Fonseca Lucinda and Maycon Moura Reboredo
    Citation: Renal Replacement Therapy 2024 10:18
  35. Chronic kidney disease (CKD) affects 10% of the general population in Western countries. Currently, CKD cannot be cured and there are only few strategies to prevent the onset of CKD, to reverse early stages of...

    Authors: Susanne M. Lang and Helmut Schiffl
    Citation: Renal Replacement Therapy 2024 10:17
  36. Physical activity is an important prognostic factor in patients undergoing hemodialysis. Walkability also affects physical activity. This study aimed to examine the effects of walkability on the physical activ...

    Authors: Yoichi Sato, Naoto Usui, Yoshifumi Abe, Daisuke Okamura, Yota Kuramochi, Sho Kojima, Nobuto Shinozaki, Yu Shimano, Nobuyuki Shirai, Kenta Mikami, Yoji Yamada and Masakazu Saitoh
    Citation: Renal Replacement Therapy 2024 10:16

    The Correction to this article has been published in Renal Replacement Therapy 2024 10:45

  37. Abnormal urine discoloration tends to be concerning for the patient and piques the interest of medical professionals. Different factors can arise in cases of urine turning blue or green. We highlight the neces...

    Authors: Stevan Kristian Lionardi, Antoninus Hengky and Sean Peter Haruman
    Citation: Renal Replacement Therapy 2024 10:15
  38. The 2020 Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) annual survey was sent to 4493 dialysis facilities in Japan.

    Authors: Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Junichi Hoshino, Kan Kikuchi, Shunsuke Goto, Eiichiro Kanda, Masatomo Taniguchi, Shigeru Nakai, Toshihide Naganuma, Takeshi Hasegawa, Kenichiro Miura, Atsushi Wada and Yoshiaki Takemoto
    Citation: Renal Replacement Therapy 2024 10:14
  39. Cinacalcet hydrochloride (cinacalcet), an oral calcimimetics for secondary hyperparathyroidism (SHPT), has been widely used worldwide. In contrast, evocalcet, an improved derivative of cinacalcet, was approved...

    Authors: Nobuo Nagano, Takayuki Ishikawa, Masashi Yamaguchi, Yuji Katsuragi, Masaaki Miya, Noriko Tamei, Shigeaki Muto, Takaaki Tsutsui, Tetsuya Ogawa and Kyoko Ito
    Citation: Renal Replacement Therapy 2024 10:13
  40. Recently, discussions have increasingly focused on “withdrawal from dialysis” among patients undergoing dialysis who experience severe brain dysfunction as post-stroke sequelae. In this context, the lack of un...

    Authors: Yusuke Watanabe, Kaima Suzuki, Tsutomu Inoue, Hiroki Kurita and Hirokazu Okada
    Citation: Renal Replacement Therapy 2024 10:12
  41. Although a deficiency in erythropoietin relative to decreased hemoglobin levels is presumed to be the predominant cause of renal anemia, other factors may also exist that are not fully understood.

    Authors: Shoichiro Daimon
    Citation: Renal Replacement Therapy 2024 10:11
  42. During continuous kidney replacement therapy (CKRT) in patients with sepsis and critical conditions, circuit coagulation can occur, often for unclear reasons. In this study, we investigate how the structure of...

    Authors: Kota Shimizu, Kazuhiro Moriyama, Naohide Kuriyama, Tomoyuki Nakamura, Takahiro Kawaji, Satoshi Komatsu and Osamu Nishida
    Citation: Renal Replacement Therapy 2024 10:10
  43. Blood purification therapy with a sulfonated polyacrylonitrile surface treated (AN69ST) hemofilter is used to treat sepsis. However, the AN69ST hemofilter has been reported to adsorb and remove therapeutic dru...

    Authors: Yoshinori Inano, Kayoko Tsuchiya, Ryota Kumano, Go Miura and Hiromitsu Nakasa
    Citation: Renal Replacement Therapy 2024 10:8
  44. Dialysis units have been concerned that the corroded metal parts of pumps used in hemodialysis might not allow sterility of the pump to be ensured due to bacterial contamination, even after cleaning and disinf...

    Authors: Minoru Nakamura, Masaya Okayama, Seya Hagiwara, Tomoyasu Nawa and Shin-ichi Yokota
    Citation: Renal Replacement Therapy 2024 10:6

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 0.9
    5-year Journal Impact Factor: N/A
    Source Normalized Impact per Paper (SNIP): 0.530
    SCImago Journal Rank (SJR): 0.315

    Speed 2023
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 138

    Usage 2023
    Downloads: 545,038
    Altmetric mentions: 139